Index by author

July 01, 2002; Volume 69,Issue 7

A

  1. Askari, Arman T.

    1. GUSTO V: Combination drug treatment of acute myocardial infarction
      Arman T. Askari, MD and A. Michael Lincoff,
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 554-560;

      The combination of abciximab in full doses and reteplase in half doses was not superior to full-dose reteplase alone, but it was “not inferior” either.

B

  1. Berger, Peter B.

    1. GUSTO V: Should it affect clinical practice?
      James L. Orford, MBCHB, MPH and Peter B. Berger, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 520-522;

      The results of GUSTO V were equivocal and should not lead physicians to change how they treat myocardial infarction.

  2. Borden, Ernest C.

    1. Malignant melanoma: Treatments emerging, but early detection is still key
      Paul Masci, DO and Ernest C. Borden, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 529-545;

      Interferon alfa-2b can increase disease-free survival in malignant melanoma, but we can have far more impact by detecting this disease earlier and by teaching patients how to recognize and possibly avoid it.

C

  1. Choueiri, Toni

    1. Why shouldn’t we use warfarin alone to treat acute venous thrombosis?
      Why shouldn’t we use warfarin alone to treat acute venous thrombosis?
      Toni Choueiri, MD and Steven R. Deitcher, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 546-548;

      Heparins produce desired levels of anticoagulation within hours, whereas warfarin takes at least 4 days.

  2. Clough, John D.

    1. In reply: Coxibs supplement: Has CCJM sold out? (April 2002)
      John D. Clough, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 568;
    2. We need your help
      John D. Clough, MD and Peter G. Studer,
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 519;

      If your copy of the Journal has a postcard on the cover, please sign it and drop it in the mail—it could save us a lot of money.

  3. Conwell, Darwin L.

    1. A 76-year-old man with septic arthritis
      Prashanthi N. Thota, MD, Madhusudhan R. Sanaka, MD and Darwin L. Conwell, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 549-553;

      What is the cause of this patient’s symptoms? A self-test.

D

  1. Deitcher, Steven R.

    1. Why shouldn’t we use warfarin alone to treat acute venous thrombosis?
      Why shouldn’t we use warfarin alone to treat acute venous thrombosis?
      Toni Choueiri, MD and Steven R. Deitcher, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 546-548;

      Heparins produce desired levels of anticoagulation within hours, whereas warfarin takes at least 4 days.

F

  1. Frisch, Emanuel

    1. Coxibs supplement: Has CCJM sold out? (April 2002)
      Emanuel Frisch, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 568;

H

  1. Hill, John

    1. Aromatase inhibitors in breast cancer: Current and evolving roles
      John Hill, MD and Halle Moore, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 561-567;

      Aromatase inhibitors are finding new uses. Already established for treating metastatic breast cancer in postmenopausal women, they are gaining acceptance as adjuvant treatment as well.

  2. Hix, John Kevin

    1. A traveler with nonhealing skin nodules
      John Kevin Hix, MD and Mikal Rahman, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 524-528;

      Questions and answers on the visible signs of diseases.

  3. Hochberg, Marc C.

    1. In reply: Coxibs supplement: Has CCJM sold out? (April 2002)
      Marc C. Hochberg, MD, MPH
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 568;

L

  1. Lincoff, A. Michael

    1. GUSTO V: Combination drug treatment of acute myocardial infarction
      Arman T. Askari, MD and A. Michael Lincoff,
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 554-560;

      The combination of abciximab in full doses and reteplase in half doses was not superior to full-dose reteplase alone, but it was “not inferior” either.

  2. Longworth, David L.

    1. A 76-year-old man with septic arthritis
      Prashanthi N. Thota, MD, Madhusudhan R. Sanaka, MD and Darwin L. Conwell, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 549-553;

      What is the cause of this patient’s symptoms? A self-test.

M

  1. Markman, Maurie

    1. Malignant melanoma: Treatments emerging, but early detection is still key
      Paul Masci, DO and Ernest C. Borden, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 529-545;

      Interferon alfa-2b can increase disease-free survival in malignant melanoma, but we can have far more impact by detecting this disease earlier and by teaching patients how to recognize and possibly avoid it.

  2. Masci, Paul

    1. Malignant melanoma: Treatments emerging, but early detection is still key
      Paul Masci, DO and Ernest C. Borden, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 529-545;

      Interferon alfa-2b can increase disease-free survival in malignant melanoma, but we can have far more impact by detecting this disease earlier and by teaching patients how to recognize and possibly avoid it.

  3. Moore, Halle

    1. Aromatase inhibitors in breast cancer: Current and evolving roles
      John Hill, MD and Halle Moore, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 561-567;

      Aromatase inhibitors are finding new uses. Already established for treating metastatic breast cancer in postmenopausal women, they are gaining acceptance as adjuvant treatment as well.

N

  1. Nally, Joseph V.

    1. Acute renal failure in hospitalized patients
      Acute renal failure in hospitalized patients
      Joseph V. Nally, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 569-574;

      Acute renal failure demands a logical approach to its prevention and early diagnosis.

O

  1. Orford, James L.

    1. GUSTO V: Should it affect clinical practice?
      James L. Orford, MBCHB, MPH and Peter B. Berger, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 520-522;

      The results of GUSTO V were equivocal and should not lead physicians to change how they treat myocardial infarction.

R

  1. Rahman, Mikal

    1. A traveler with nonhealing skin nodules
      John Kevin Hix, MD and Mikal Rahman, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 524-528;

      Questions and answers on the visible signs of diseases.

S

  1. Sanaka, Madhusudhan R.

    1. A 76-year-old man with septic arthritis
      Prashanthi N. Thota, MD, Madhusudhan R. Sanaka, MD and Darwin L. Conwell, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 549-553;

      What is the cause of this patient’s symptoms? A self-test.

  2. Stoller, James K.

    1. A 76-year-old man with septic arthritis
      Prashanthi N. Thota, MD, Madhusudhan R. Sanaka, MD and Darwin L. Conwell, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 549-553;

      What is the cause of this patient’s symptoms? A self-test.

  3. Studer, Peter G.

    1. We need your help
      John D. Clough, MD and Peter G. Studer,
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 519;

      If your copy of the Journal has a postcard on the cover, please sign it and drop it in the mail—it could save us a lot of money.

T

  1. Thota, Prashanthi N.

    1. A 76-year-old man with septic arthritis
      Prashanthi N. Thota, MD, Madhusudhan R. Sanaka, MD and Darwin L. Conwell, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 549-553;

      What is the cause of this patient’s symptoms? A self-test.

W

  1. Williams, Marc

    1. A traveler with nonhealing skin nodules
      John Kevin Hix, MD and Mikal Rahman, MD
      Cleveland Clinic Journal of Medicine July 2002, 69 (7) 524-528;

      Questions and answers on the visible signs of diseases.

Back to top

In this issue